Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine

NCT04477096 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: HS-10234
DRUG: Emtricitabine

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.